NEW ARTICLE: Clinical Trial Design Has Never Been More Important for Psychedelics psychedelicinvest.com/clinical-trial…

PharmaDrug’s Sairiyo Therapuetics Provides Strategic Plans to Advance PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases: psychedelicinvest.com/pharmadrugs-sa…

Optimi Health & ATMA Receive No Objection Letter from Health Canada for Phase 2 Clinical Trial: psychedelicinvest.com/optimi-health-…

Awakn Announces Key Progress in Its Aminoindane Pre-Clinical Program: psychedelicinvest.com/awakn-announce…

Revive Therapeutics Provides (Yet Another) Update on Bucillamine for Nerve Agent Exposure: psychedelicinvest.com/revive-therape…

Cybin Announces Results of Annual and Special Meeting of Shareholders and Share Consolidation: psychedelicinvest.com/cybin-announce…

Psyence Biomed to Present at the H.C. Wainwright 26th Annual Global Investment Conference, September 9th-11th, 2024: psychedelicinvest.com/psyence-biomed…

MindBio CEO Provides Video Update to Shareholders on Progress of World First, Government Approved Microdosing Clinical Trials: psychedelicinvest.com/mindbio-ceo-pr…

NRx Pharma Subsidiary HOPE Therapeutics Secures $30M to Buy Ketamine Clinics: psychedelicinvest.com/nrx-pharma-sub…

Red Light Holland Reports First Quarter 2025 Results: psychedelicinvest.com/red-light-holl…

In case you missed it.... MAPS Awards Grant for Pilot MDMA-assisted Massed Exposure Therapy Trial: psychedelicinvest.com/maps-awards-gr…

Psyence Biomed Announces Registration Statement on Form F-1 for Up to $25 Million Equity Line of Credit with White Lion Capital, LLC, Declared Effective by SEC: psychedelicinvest.com/psyence-biomed…

Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment: psychedelicinvest.com/clearmind-medi…

SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamine-Based Combination: psychedelicinvest.com/scisparc-clear…

Red Light Holland Launches FarmCare Health to Revolutionize Healthcare with Farm-Fresh Food Prescriptions: psychedelicinvest.com/red-light-holl…

Cybin to Participate in the H.C. Wainwright 26th Annual Global Investment Conference: psychedelicinvest.com/cybin-to-parti…

Psyence Biomed Announces Worldwide Exclusive Licensing Agreement with PsyLabs to Supply Nature-Derived Psilocybin to be Evaluated as a Potential Treatment for Alcohol Use Disorder (AUD) and Other Substance Use Disorders (SUDs): psychedelicinvest.com/psyence-biomed…

atai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference: psychedelicinvest.com/atai-life-scie…

MindMed to Participate in September Investor Conferences: psychedelicinvest.com/mindmed-to-par…

Revitalist Lifestyle and Wellness Ltd. Partners with Wake Network to Launch Lion’s Brain Supplements for Enhanced Mental Clarity and Wellbeing: psychedelicinvest.com/revitalist-lif…